ABCB1/P-gp |
ATP-binding cassette transporters B1/P-glycoprotein |
ACSL6 |
Acyl-CoA synthetase long chain family member 6 |
AD |
Alzheimer’s disease |
ADAS-Cog |
AD Assessment Scale–Cognitive Subscale |
ADME |
absorption, distribution, metabolism, excretion |
ApoE4 |
apolipoprotein ε4 |
APP |
amyloïd precursor protein |
ARA |
arachidonic acid |
AUC |
area under the curve |
Aβ |
β-amyloid |
BBB |
blood–brain barrier |
BCEC |
brain capillary endothelial cells |
CAA |
cerebral amyloid angiopathy |
CAIDE |
Cardiovascular Risk Factors, Aging, and Incidence of Dementia |
CNS |
central nervous system |
CSF |
cerebrospinal fluid |
DHA |
docosahexaenoic acid |
EGCG |
epigallocatechin gallate |
ENS |
enteric nervous system |
EPA |
eicosapentaenoic acid |
FA |
fatty acid |
FAPB5 |
fatty acid binding protein 5 |
GLP-1 |
glucagon-like-peptide 1 |
LRP1 |
low-density lipoprotein receptor-related protein 1 |
MEC |
minimum effective concentration |
MMSE |
Mini-Mental State Examination |
n-3 PUFAs |
omega-3 polyunsaturated fatty acids |
NPs |
natural products |
PD |
Parkinson’s disease |
PK |
pharmacokinetic |
RAGE |
receptor for advanced glycation end-products |
RCT |
randomized controlled trial |
T2D |
type 2 diabetes |
TfR |
transferrin receptor. |